Prospects for an AIDS vaccine: Encourage innate immunity

AIDS

Volumn 18, Issue 15, 2004, Pages 2085-2086

  Levy, Jay A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNITY; LENTIVIRINAE; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE; VIRUS REPLICATION;

AIDS VACCINES; HUMANS; IMMUNITY, NATURAL;

EID: 7744227198     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200410210-00014     Document Type: Editorial

References (20)

1. Desrosiers RC. Prospects for an AIDS vaccine. Nature Med 2004, 10:221-223.
2. Levy JA. The importance of the innate immune system in controlling HIV infection and disease. Trends Immunol 2001, 22:312-316.
3. Schwarz K, Storni T, Manolova V, Didierlaurent A, Sirad J-C, Rothlisberger P, et al. Role of Toll-like reeptors in costimulating cytotoxic T cell responses. Eur J Immunol 2003, 33:1465-1470.
4. Loré K, Betts MR, Brenchley JM, Kuruppu J, Khojasteh S, Perfetto S, et al. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus - and HIV-1 -specific T cell responses. J Immunol 2003, 171:4320-4328.
5. Lu W, Wu X, Lu Y, Guo W, Andrieu J-M. Therapeutic dendritic-cell vaccine for simian AIDS. Nature Med 2003, 9:27-32.
6. Lehner T, Mitchell E, Bergmeier L, Singh M, Spallek R, Cranage M, et al. The role of gamma delta T cells in generating antiviral factors and beta-chemokines in protection against mucosal simian immunodeficiency virus infection. Eur J Immunol 2000, 30:2245-2256.
7. Tenner-Racz K, Hennig CS, Uberla K, Stoiber H, Ignatius R, Henney J, et al. Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus. Proc Natl Acad Sci USA 2004, 101:3017-3022.
8. Soumelis V, Scott I, Gheyas F, Bouhour D, Cozon G, Cotte L, et al. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 2001, 98:906-912.
9. Pulendran B, Banchereau J, Burkeholder S, Kraus E, Guinet E, Chalouni C, et al. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J Immunol 2000, 165:566-572.
10. Chen W, Antonenko S, Sederstrom JM, Liang X, Chan AS, Kanzler H, et al. Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors. Blood 2004, 103:2547-2553.
11. Levy JA, Mackewicz CE, Barker E. Controlling HIV pathogenesis: the role of noncytotoxic anti-HIV activity of CD8+ cells. Immunol Today 1996, 17:217-224.
12. Castro BA, Homsy J, Lennette E, Murthy KK, Eichberg JW, Levy JA. HIV-1 expression in chimpanzees can be activated by CD8+ cell depletion or CMV infection. Clin Immunol Immunopathol 1992, 65:227-233.
13. Matano T, Shibata R, Siemon C, Connors M, Lane HC, Martin MA. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol 1998, 72:164-169.
14. 14; Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999, 283:857-860.
15. Barker E, Mackewicz CE, Levy JA. Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival. Proc Natl Acad Sci USA 1995, 92:11135-11139.
16. Castelli J, Thomas E, Liu Y-J, Levy JA. Mature dendritic cells can enhance CD8+ cell noncytotoxic Anti-HIV responses: the role of IL-15. Blood 2004, 103:2699-2704.
17. Levy JA. What can be achieved with an HIV vaccine? Lancet 2001, 357:223-224.
18. Krug A, Towarowski A, Britsch S, Rothenfusser S, Hornung V, Bals R, et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol 2001, 31:3026-3037.
19. Dumais N, Patrick A, Moss RB, Davis HL, Rosenthal KL. Mucosal immunization with inactivated human immunodeficiency virus plus CpG oligodeoxynucleotides induces genital immune responses and protection against intravaginal challenge. J Infect Dis 2002, 186:1098-1105.
20. Verthlyi D, Wang VW, Lifson JD, Klinman DM. CpG oligodeoxynucleotides improve the response to hepatitis B immunization in healthy and SIV-infected rhesus macaques. AIDS 2004, 18:1003-1008.